The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection

NCT00001036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Thymalfasin
DRUG: Interleukin-2, Polyethylene Glycolated
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)